Metformin increases the novel adipokine adipolin/CTRP12: Role of the AMPK pathway

Journal of Endocrinology

Volumn 219, Issue 2, 2013, Pages 101-108

  Tan, Bee K ^a   Chen, Jing ^a   Adya, Raghu ^a   Ramanjaneya, Manjunath ^a   Patel, Vanlata ^a   Randeva, Harpal S ^a  

^a UNIVERSITY OF WARWICK   (United Kingdom)

Author keywords

Adipokine; Adipolin; Metformin; Polycystic ovary syndrome

Indexed keywords

ADIPOCYTOKINE; ADIPOLIN; ANDROGEN; ANDROSTENEDIONE; BETA ACTIN; ESTRADIOL; GLUCOSE; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE KINASE; METFORMIN; PRASTERONE SULFATE; SEX HORMONE BINDING GLOBULIN; TESTOSTERONE; TRIACYLGLYCEROL; UNCLASSIFIED DRUG;

ADULT; ARTICLE; BODY MASS; CLINICAL ARTICLE; CONTROLLED STUDY; ENZYME LINKED IMMUNOSORBENT ASSAY; EXPLANT; FEMALE; GENE EXPRESSION; HOMEOSTASIS MODEL ASSESSMENT; HUMAN; HUMAN TISSUE; OVARY POLYCYSTIC DISEASE; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; PROTEIN EXPRESSION; REAL TIME POLYMERASE CHAIN REACTION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SCORING SYSTEM; SIGNAL TRANSDUCTION; SUBCUTANEOUS FAT; TISSUE LEVEL; WAIST HIP RATIO; WESTERN BLOTTING;

ADIPOKINE; ADIPOLIN; METFORMIN; POLYCYSTIC OVARY SYNDROME;

ADIPOKINES; ADULT; AMP-ACTIVATED PROTEIN KINASES; BODY MASS INDEX; CASE-CONTROL STUDIES; FEMALE; GLUCOSE; HUMANS; HYPOGLYCEMIC AGENTS; METFORMIN; POLYCYSTIC OVARY SYNDROME; RNA, MESSENGER; SIGNAL TRANSDUCTION; SUBCUTANEOUS FAT; WAIST-HIP RATIO;

EID: 84885811491     PISSN: 00220795     EISSN: 14796805     Source Type: Journal    
DOI: 10.1530/JOE-13-0277     Document Type: Article

References (26)

1. Bustin SA, Benes V, Garson JA, Hellemans J, Huggett J, KubistaM, Mueller R, Nolan T, Pfaffl MW, Shipley GL et al. 2009 The MIQE guidelines: minimum information for publication of quantitative real-time PCR experiments. Clinical Chemistry 55 611-622. (doi:10.1373/clinchem.2008.112797)
2. Diamanti-Kandarakis E 2006 Insulin resistance inPCOS. Endocrine 30 13-17. (doi:10.1385/ENDO:30:1:13)
3. Diamanti-Kandarakis E, Paterakis T & Kandarakis HA 2006 Indices of low-grade inflammation in polycystic ovary syndrome. Annals of the New York Academy of Sciences 1092 175-186. (doi:10.1196/annals.1365.015)
4. Dunaif A 1997 Insulin resistance and the polycystic ovary syndrome: mechanism and implications for pathogenesis. Endocrine Reviews 18 774-800. (doi:10.1210/er.18.6.774)
5. Enomoto T, Ohashi K, Shibata R, Higuchi A, Maruyama S, Izumiya Y, Walsh K, Murohara T & Ouchi N 2011 Adipolin/C1qdc2/CTRP12 protein functions as an adipokine that improves glucose metabolism. Journal of Biological Chemistry 286 34552-34558. (doi:10.1074/jbc. M111.277319)
6. Fauser B 2004 Revised 2003 consensus on diagnostic criteria and long-term health risks related to polycystic ovary syndrome (PCOS). Human Reproduction 19 41-47. (doi:10.1193/humrep/deh198)
7. Fried SK & Moustaid-Moussa N 2001 Culture of adipose tissue and isolated adipocytes. Methods in Molecular Biology 155 197-212. (doi:10.1385/1-59259-231-7:197)
8. Hotamisligil GS, Shargill NS & Spiegelman BM 1993 Adipose expression of tumour necrosis factor-a: direct role in obesity-linked insulin resistance. Science 259 87-91. (doi:10.1126/science.7678183)
9. Inzucchi SE, Maggs DG, Spollett GR, Page SL, Rife FS, Walton V & Shulman GI 1998 Efficacy and metabolic effects of metformin and troglitazone in type II diabetes mellitus. New England Journal of Medicine 338 867-872. (doi:10.1056/NEJM199803263381303)
10. Johnson AB, Webster JM, Sum CF, Heseltine L, Argyraki M, Cooper BG & Taylor R 1993 The impact of metformin therapy on hepatic glucose production and skeletal muscle glycogen synthase activity in overweight type II diabetic patients. Metabolism 42 1217-1222. (doi:10.1016/0026-0495(93)90284-U)
11. Kershaw EE & Flier JS 2004 Adipose tissue as an endocrine organ. Journal of Clinical Endocrinology and Metabolism 89 2548-2556. (doi:10.1210/jc.2004-0395)
12. Kubaszek A, Pihlajamäki J, Komarovski V, Lindi V, Lindström J, Eriksson J, Valle TT, Hämäläinen H, Ilanne-Parikka P, Keinänen-Kiukaanniemi S et al. 2003 Promoter polymorphisms of the TNF-α (G-308A) and IL-6 (C-174G) genes predict the conversion from impaired glucose tolerance to type 2 diabetes: the Finnish Diabetes Prevention Study. Diabetes 52 1872-1876. (doi:10.2337/diabetes.52.7.1872)
13. Lehrke M & Lazar MA 2004 Inflamed about obesity. Nature Medicine 10 126-127. (doi:10.1038/nm0204-126)
14. Lihn AS, Jessen N, Pedersen SB, Lund S & Richelsen B 2004 ICAR stimulates adiponectin and inhibits cytokines in adipose tissue. Biochemical and Biophysical Research Communications 316 853-858. (doi:10.1016/j.bbrc.2004.02.139)
15. Lumeng CN, Deyoung SM, Bodzin JL & Saltiel AR 2007 Increased inflammatory properties of adipose tissue macrophages recruited during diet-induced obesity. Diabetes 56 16-23. (doi:10.2337/db06-1076)
16. Matthews DR, Hosker JP, Rudenski AS, Naylor BA, Treacher DF & Turner RC 1985 Homeostasis model assessment: insulin resistance and b-cell function from fasting plasma glucose and insulin concentrations in man. Diabetologia 28 412-419. (doi:10.1007/BF00280883)
17. Nardo LG & Rai R 2001 Metformin therapy in the management of polycystic ovary syndrome: endocrine, metabolic and reproductive effects. Gynecological Endocrinology 15 373-380. (doi:10.1080/gye.15.5.373.380)
18. Perriello G, Misericordia P, Volpi E, Santucci A, Santucci C, Ferrannini E, Ventura MM, Santeusanio F, Brunetti P & Bolli GB 1994 Acute antihyperglycemic mechanisms of metformin in NIDDM: evidence for suppression of lipid oxidation and hepatic glucose production. Diabetes 43 920-928. (doi:10.2337/diabetes.43.7.920)
19. Pfaffl MW 2001 A new mathematical model for relative quantification in real-time RT-PCR. Nucleic Acids Research 29 e45. (doi:10.1193/nar/29.9.e45)
20. Sell H, Dietze-Schroeder D, Eckardt K & Eckel J 2006 Cytokine secretion by human adipocytes is differentially regulated by adiponectin, AICAR, and troglitazone. Biochemical and Biophysical Research Communications 343 700-706. (doi:10.1016/j.bbrc.2006.03.010)
21. Sun J, Xu Y, Deng H, Sun S, Dai Z & Sun Y 2010 Intermittent high glucose exacerbates the aberrant production of adiponectin and resistin through mitochondrial superoxide overproduction in adipocytes. Journal of Molecular Endocrinology 44 179-185. (doi:10.1677/JME-19-0088)
22. Thorne A, Lonnqvist F, Apelman J, Hellers G & Arner P 2002 A pilot study of long-term effects of a novel obesity treatment: omentectomy in connection with adjustable gastric banding. International Journal of Obesity and Related Metabolic Disorders 26 193-199. (doi:10.1038/sj.ijo.0801871)
23. Wajchenberg BL 2000 Subcutaneous and visceral adipose tissue: their relation to the metabolic syndrome. Endocrine Reviews 21 697-738. (doi:10.1210/er.21.6.697)
24. Wei Z, Peterson JM, Lei X, Cebotaru L, Wolfgang MJ, Baldeviano GC & Wong GW 2012 C1q/TNF-related protein-12 (CTRP12), a novel adipokine that improves insulin sensitivity and glycemic control in mouse models of obesity and diabetes. Journal of Biological Chemistry 287 10301-10315. (doi:10.1074/jbc.M111.303651)
25. Weisberg SP,McCann D, Desai M, RosenbaumM, Leibel RL& FerranteAWJr 2003 Obesity is associated with macrophage accumulation in adipose tissue. Journal of Clinical Investigation 112 1796-1808. (doi:10.1172/JCI19246)
26. Xu H, Barnes GT, Yang Q, TanG, YangD, Chou CJ, Sole J,Nichols A, Ross JS, Tartaglia LAet al. 2003 Chronic inflammation infat plays a crucial role in the development of obesity related insulin resistance. Journal of Clinical Investigation 112 1821-1830. (doi:10.1172/JCI19451)